Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.56M Sell
7,283
-99
-1% -$35.3K 0.94% 25
2025
Q4
$2.84M Buy
7,382
+106
+1% +$33.6K 1% 24
2025
Q3
$2.05M Buy
7,276
+30
+0.4% +$8.7K 0.75% 25
2025
Q2
$2.02M Sell
7,246
-183
-2% -$51.8K 0.81% 25
2025
Q1
$2.31M Buy
7,429
+6
+0.1% +$1.77K 0.99% 20
2024
Q4
$1.93M Buy
7,423
+151
+2% +$44.8K 0.84% 24
2024
Q3
$2.34M Sell
7,272
-116
-2% -$37.9K 1.05% 21
2024
Q2
$2.31M Buy
7,388
+5
+0.1% +$1.47K 1.14% 18
2024
Q1
$2.1M Sell
7,383
-140
-2% -$41K 1.06% 23
2023
Q4
$2.17M Sell
7,523
-20
-0.3% -$5.45K 1.16% 22
2023
Q3
$2.03M Sell
7,543
-264
-3% -$65.9K 1.17% 18
2023
Q2
$1.73M Sell
7,807
-346
-4% -$80.3K 0.95% 26
2023
Q1
$1.97M Sell
8,153
-221
-3% -$54.2K 1.13% 17
2022
Q4
$2.2M Buy
8,374
+5
+0.1% +$1.34K 1.34% 12
2022
Q3
$1.89M Buy
8,369
+280
+3% +$67.9K 1.27% 18
2022
Q2
$1.97M Buy
8,089
+405
+5% +$99.2K 1.28% 18
2022
Q1
$1.86M Buy
7,684
+255
+3% +$58.6K 1.08% 21
2021
Q4
$1.67M Buy
7,429
+116
+2% +$24.5K 0.97% 25
2021
Q3
$1.55M Buy
7,313
+574
+9% +$132K 1% 25
2021
Q2
$1.64M Buy
6,739
+54
+0.8% +$13.3K 1.16% 23
2021
Q1
$1.66M Buy
6,685
+17
+0.3% +$4.06K 1.24% 23
2020
Q4
$1.53M Buy
+6,668
New +$1.54M 1.37% 21

Other funds holding AMGN

Sittner & Nelson's AMGN Position: Q1 2026 in Review

Sittner & Nelson reduced its Amgen (AMGN) stake by 1.3% in Q1 2026, selling an estimated $35.3K and leaving 7,283 shares worth $2.56M. The position accounts for 0.94% of the portfolio, ranked #25.

Sittner & Nelson first reported a position in AMGN in Q4 2020 and has held it in 22 quarters since. The position peaked at $2.84M in Q4 2025. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Sittner & Nelson held 7,283 shares of Amgen worth $2.56M as of Q1 2026.
  • Sittner & Nelson sold 99 Amgen shares in Q1 2026, an estimated $35.3K.
  • Amgen made up 0.94% of Sittner & Nelson's portfolio in Q1 2026, its #25 holding.
  • Sittner & Nelson first reported a position in Amgen in Q4 2020 and has held it in 22 quarters since.
  • Sittner & Nelson's Amgen position peaked at $2.84M in Q4 2025.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Sittner & Nelson's 13F filing for Q1 2026, filed 12 May 2026.